Director Rubenstein acquires 8,116 Moderna (NASDAQ: MRNA) shares

Rhea-AI Filing Summary

Moderna director David M. Rubenstein exercised restricted stock units to receive 8,116 shares of Common Stock. The RSUs converted into common stock on a one-for-one basis and vested in full on April 30, 2026.

Following this vesting and conversion, Rubenstein directly holds 9,643 shares of Moderna common stock. The filing shows no open-market purchases or sales, only the automatic conversion of a stock-based compensation award into shares.

Insider Trade Summary

8,116 shares exercised/converted

Mixed 2 txns

Insider Rubenstein David M.

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	8,116	$0.00	--
Exercise	Common Stock	8,116	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 9,643 shares (Direct, null)

Footnotes (1)

1. Restricted stock units convert into common stock on a one-for-one basis. The shares subject to this restricted stock unit award vested in full on April 30, 2026.

Key Figures

RSUs converted: 8,116 shares Shares held after transaction: 9,643 shares Exercise/Conversion price: $0.00 per share

3 metrics

RSUs converted 8,116 shares Restricted stock units converting into Common Stock on April 30, 2026

Shares held after transaction 9,643 shares Direct Moderna Common Stock holdings after RSU conversion

Exercise/Conversion price $0.00 per share RSU conversion price as stock-based compensation, not an open-market trade

Key Terms

Restricted Stock Units, derivative security, Common Stock

3 terms

Restricted Stock Units financial

"The shares subject to this restricted stock unit award vested in full on April 30, 2026."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Common Stock financial

"Restricted stock units convert into common stock on a one-for-one basis."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rubenstein David M.

(Last) (First) (Middle)

C/O MODERNA, INC.

325 BINNEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		M(1)		8,116	A	(1)	9,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	04/30/2026		M(1)			8,116	(2)	(2)	Common Stock	8,116	$0	0	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The shares subject to this restricted stock unit award vested in full on April 30, 2026.

	/s/ James Dillon, As Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Moderna (MRNA) director David M. Rubenstein report?

David M. Rubenstein reported exercising restricted stock units to acquire 8,116 shares of Moderna Common Stock. The RSUs converted into shares on a one-for-one basis as part of his stock-based compensation, rather than an open-market purchase or sale.

How many Moderna (MRNA) shares does David M. Rubenstein hold after this Form 4?

After the RSU conversion, David M. Rubenstein directly holds 9,643 shares of Moderna Common Stock. This total reflects the addition of 8,116 shares from vested restricted stock units, as disclosed in the Form 4 insider filing for April 30, 2026.

Were any Moderna (MRNA) shares sold in David M. Rubenstein’s latest Form 4 filing?

No shares were sold in this filing. The Form 4 shows only the exercise and conversion of 8,116 restricted stock units into Common Stock, with no open-market sale or disposition transactions reported for David M. Rubenstein on April 30, 2026.

What do the restricted stock units in Moderna (MRNA) director Rubenstein’s filing represent?

The restricted stock units represent stock-based compensation that converts into common shares when vested. In this case, 8,116 RSUs vested in full on April 30, 2026 and converted into 8,116 Moderna Common Stock shares, as described in the Form 4 footnotes.

On what date did David M. Rubenstein’s Moderna (MRNA) restricted stock units vest?

The restricted stock units vested in full on April 30, 2026. On that date, 8,116 RSUs converted into an equal number of Moderna Common Stock shares, according to the Form 4 footnotes describing the vesting and conversion terms for this award.